FAQ/Help |
Calendar |
Search |
Today's Posts |
08-29-2020, 02:52 PM | #1 | |||
|
||||
Senior Member
|
There is a new MS drug that has just received FDA approval. I've been trying to post a link to an article about it. I'll give it one more try.
That didn't work. I don't know why I sometimes get a message saying that my post request can't be fulfilled, but I'll try posting without the link and see what happens. The drug's brand name is Kesimpta (ofatumumab) and is described as follows in the article I couldn't link to: Quote:
__________________
Repeal the law of gravity! MS diagnosed 1980. Type 2 diabetes, osteoarthritis, osteopenia. Avonex 2002-2005. Copaxone 6/4/07-5/15/10. Currently: Glatopa (generic Copaxone), 40mg 3 times/week, 12/16/20 - 3/16/24 Last edited by agate; 08-29-2020 at 06:57 PM. |
|||
Reply With Quote |
|
|
Similar Threads | ||||
Thread | Forum | |||
Ofatumumab (Kesimpta) for RRMS has FDA approval | Multiple Sclerosis | |||
ALS drug receives FDA approval | ALS News & Research | |||
UK to speed up drug approval ... | Parkinson's Disease | |||
FDA To Strengthen Generic Drug Program...Streamline Generic Drug Approval Process | Parkinson's Disease |